Pembrolizumab In Central Nervous System Metastases
Clinical trial NCT02886585 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02886585
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2027-06-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.